Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices 61489 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR Part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Additional information on all bank 

holding companies may be obtained 

from the National Information Center 

website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than October 29, 

2010. 

A. Federal Reserve Bank of Atlanta 

(Clifford Stanford, Vice President) 1000 

Peachtree Street, N.E., Atlanta, Georgia 

30309: 

1. PFGBI, LLC, McDonough, Georgia; 

to become a bank holding company by 

acquiring approximately 50.8 percent of 

the outstanding voting shares of 

Montgomery County Bankshares, Inc., 

and its subsidary, Montgomery County 

Bank & Trust, both of Ailey, Georgia. 

Board of Governors of the Federal Reserve 

System, September 30, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–24901 Filed 10–4–10; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Minority Health 

AGENCY: Office of Minority Health, 

Office of the Assistant Secretary for 

Health, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice of meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (DHHS) is hereby giving notice 

that the Advisory Committee on 

Minority Health (ACMH) will hold a 

meeting. This meeting is open to the 

public. Preregistration is required for 

both public attendance and comment. 

Any individual who wishes to attend 

the meeting and/or participate in the 

public comment session should e-mail 

acmh@osophs.dhhs.gov. 

DATES: The meeting will be held on 

Monday, November 15, 2010 from 9 

a.m. to 5 p.m. and Tuesday, November 

16, 2010 from 9 a.m. to 1 p.m. 

ADDRESSES: The meeting will be held at 

the Doubletree Hotel, 1515 Rhode Island 

Ave., NW., Washington, DC 20005. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Monica A. Baltimore, Tower Building, 

1101 Wootton Parkway, Suite 600, 

Rockville, Maryland 20852. Phone: 240– 

453–2882, Fax: 240–453–2883. 

SUPPLEMENTARY INFORMATION: In 

accordance with Public Law 105–392, 

the ACMH was established to provide 

advice to the Deputy Assistant Secretary 

for Minority Health in improving the 

health of each racial and ethnic 

minority group and on the development 

of goals and specific program activities 

of the Office of Minority Health. 

Topics to be discussed during this 

meeting will include increasing the 

health care workforce and strategies to 

improve the health of racial and ethnic 

minority populations through the 

development of health policies and 

programs that will help eliminate health 

disparities, as well as other related 

issues. 

Public attendance at the meeting is 

limited to space available. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

designated contact person at least 

fourteen (14) business days prior to the 

meeting. Members of the public will 

have an opportunity to provide 

comments at the meeting. Public 

comments will be limited to three 

minutes per speaker. Individuals who 

would like to submit written statements 

should mail or fax their comments to 

the Office of Minority Health at least 

seven (7) business days prior to the 

meeting. Any members of the public 

who wish to have printed material 

distributed to ACMH committee 

members should submit their materials 

to the Executive Secretary, ACMH, 

Tower Building, 1101 Wootton 

Parkway, Suite 600, Rockville, 

Maryland 20852, prior to close of 

business November 5, 2010. 

Dated: September 23, 2010. 

Garth N. Graham, 

Deputy Assistant Secretary for Minority 

Health, Office of Minority Health, Office of 

the Assistant Secretary for Health, Office of 

the Secretary, U.S. Department of Health and 

Human Services. 

[FR Doc. 2010–24880 Filed 10–4–10; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Renewal of Declaration Regarding 

Emergency Use of Doxycycline Hyclate 

Tablets Accompanied by Emergency 

Use Information 

AGENCY: Office of the Secretary (OS), 

HHS. 

ACTION: Notice. 

SUMMARY: The Secretary of Homeland 

Security determined on September 23, 

2008 that there is a significant potential 

for a domestic emergency involving a 

heightened risk of attack with a 

specified biological, chemical, 

radiological, or nuclear agent or 

agents—in this case, Bacillus anthracis. 

On the basis of this determination, the 

Secretary of Health and Human Services 

is renewing the October 1, 2008 

declaration by former Secretary Michael 

O. Leavitt of an emergency justifying the 

authorization of emergency use of 

doxycycline hyclate tablets 

accompanied by emergency use 

information subject to the terms of any 

authorization issued by the Food and 

Drug Commissioner under 21 U.S.C. 

360bbb–3(a). This notice is being issued 

in accordance with section 564(b)(4) of 

the Federal Food, Drug, and Cosmetic 

Act, 21 U.S.C. 360bbb–3(b)(4). 

DATES: This Notice and referenced HHS 

declaration are effective as of October 1, 

2010. 

FOR FURTHER INFORMATION CONTACT: 

Nicole Lurie, MD MSPH, Assistant 

Secretary for Preparedness and 

Response, Office of the Secretary, 

Department of Health and Human 

Services, 200 Independence Avenue, 

SW., Washington, DC 20201, Telephone 

(202) 205–2882 (this is not a toll free 

number). 

SUPPLEMENTARY INFORMATION: On 

September 23, 2008, former Secretary of 

Homeland Security, Michael Chertoff, 

determined that there is a significant 

potential for a domestic emergency, 

involving a heightened risk of attack 

mstockstill on DSKH9S0YB1PROD with NOTICES

61490 Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices 

1Pursuant to section 564(b)(4) of the FFDCA, 

notice of the determination by the Secretary, DHS, 

and the declaration by the Secretary, HHS, was 

provided at 73 FR 58242 (October 6, 2008). 

with a specified biological, chemical, 

radiological, or nuclear agent or 

agents—in this case, Bacillus anthracis, 

although there is no current domestic 

emergency involving anthrax, no 

current heightened risk of an anthrax 

attack, and no credible information 

indicating an imminent threat of an 

attack involving Bacillus anthracis. 

Pursuant to section 564(b) of the Federal 

Food, Drug and Cosmetic Act, 21 U.S.C. 

360bbb–3(b), and on the basis of such 

determination, on October 1, 2008, 

former Secretary of Health and Human 

Services, Michael O. Leavitt, declared 

an emergency justifying the 

authorization of the emergency use of 

doxycycline hyclate tablets 

accompanied by emergency use 

information subject to the terms of any 

authorization issued under 21 U.S.C. 

360bbb–3(a).1 Pursuant to section 

564(b)(2)(B) of the Federal Food, Drug 

and Cosmetic Act, 21 U.S.C. 360bbb– 

3(b), and on the basis of Secretary 

Chertoff’s September 23, 2008 

determination, I hereby renew former 

Secretary Leavitt’s October 1, 2008 

declaration of an emergency, which I 

previously renewed on October 1, 2009, 

justifying the authorization of the 

emergency use of doxycycline hyclate 

tablets accompanied by emergency use 

information subject to the terms of any 

authorization issued under 21 U.S.C. 

360bbb–3(a). I am issuing this notice in 

accordance with section 564(b)(4) of the 

Federal Food, Drug, and Cosmetic Act, 

21 U.S.C. 360bbb–3(b)(4). 

Dated: September 24, 2010. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. 2010–24840 Filed 9–30–10; 11:15 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Voluntary Establishment of 

Paternity—NPRM. 

OMB No.: 0970–0175. 

Description: Section 466(a)(5)(C) of 

the Social Security Act requires States 

to pass laws ensuring a simple civil 

process for voluntarily acknowledging 

paternity under which the State must 

provide that the mother and putative 

father must be given notice, orally and 

in writing, of the benefits and legal 

responsibilities and consequences of 

acknowledging paternity. The 

information is to be used by hospitals, 

birth record agencies, and other entities 

participating in the voluntary paternity 

establishment program that collect 

information from the parents of children 

that are born out of wedlock. 

Respondents: The parents of children 

that are born out of wedlock. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

None ................................................................................................................. 1,167,097 1 0.17 198,406.49 

Estimated Total Annual Burden Hours: .................................................... ........................ ........................ ........................ 198,406.49 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: September 30, 2010. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2010–24893 Filed 10–4–10; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0502] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; National Consumer 

Surveys on Understanding the Risks 

and Benefits of FDA-Regulated Medical 

Products 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information and to allow 60 days for 

mstockstill on DSKH9S0YB1PROD with NOTICES